BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus...

Published on 13 Nov 2024 on Benzinga · via AOL

On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnology...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Best German Stocks To Buy Now. In this article, we are goin...

Insider Monkey · via Yahoo Finance 20 Nov 2024

To gain an edge, this is what you need to know today. Please click here for an enlarged chart of ...

Benzinga 16 Nov 2024

Tesla, Adobe among Friday's market cap stock movers

Investing.com 16 Nov 2024

As of the time of this writing, in premarket trading, MRNA shares are sitting around $39.18. Pfiz...

FastCompany · via Yahoo Finance 16 Nov 2024

Tesla, Adobe among Friday's market cap stock movers

Investing.com 16 Nov 2024

BioNTech SE (BNTX) has released an update. BioNTech SE is entering a new phase of growth, focusin...

TipRanks · via Yahoo Finance 16 Nov 2024

(Bloomberg) -- Shares of vaccine makers plunged after President-elect Donald Trump nominated Robe...

Bloomberg · via Yahoo Finance 15 Nov 2024

Free Report) announced that it has entered into a definitive agreement to acquire China-based...

Zacks 14 Nov 2024

On Wednesday, BioNTech SE (NASDAQ:BNTX) agreed to acquire Biotheus, a clinical-stage biotechnolog...

Benzinga · via AOL 13 Nov 2024

Amazon, Chevron lead Wednesday's market cap stock movers

Investing.com 13 Nov 2024